Search research articles
Contact Us
Filters
Showing results (1-10 of 277) with videos related to
Page
of 28
Sort By:
Postgraduate Medicine
|
April 1, 2009
Improving microvascular outcomes in patients with diabetes through management of hypertension
Janet B McGill
Therapeutic Advances in Endocrinology and Metabolism
|
November 28, 2012
Linagliptin for type 2 diabetes mellitus: a review of the pivotal clinical trials
Janet B McGill
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
April 15, 2014
The SGLT2 Inhibitor Empagliflozin for the Treatment of Type 2 Diabetes Mellitus: a Bench to Bedside Review
Janet B McGill
Postgraduate Medicine
|
June 12, 2014
Anti-diabetes therapy: safety considerations for patients with impaired kidney function
Janet B McGill
Medical Teacher
|
August 24, 2021
Using reflection to confront mistakes: Reframing failure for success
Raquel B McGill
Current Gastroenterology Reports
|
February 15, 2001
Liver biopsy: when, how, by whom, and where?
D B McGill
The Journal of Family Practice
|
September 12, 2009
Selecting among ADA/EASD tier 1 and tier 2 treatment options
Janet B McGill
Current Diabetes Reviews
|
April 21, 2012
Pharmacotherapy in type 2 diabetes: a functional schema for drug classification
Janet B McGill
Vascular Health and Risk Management
|
June 12, 2010
Optimal use of beta-blockers in high-risk hypertension: a guide to dosing equivalence
Janet B McGill
International Journal of Clinical Practice. Supplement
|
October 5, 2010
Liraglutide: effects beyond glycaemic control in diabetes treatment
J B McGill
Page
of 28
Search research articles
Search
Showing results (1-10 of 277) with videos related to
Sort By:
Page
of 28
Postgraduate Medicine
|
April 1, 2009
Improving microvascular outcomes in patients with diabetes through management of hypertension
Janet B McGill
Therapeutic Advances in Endocrinology and Metabolism
|
November 28, 2012
Linagliptin for type 2 diabetes mellitus: a review of the pivotal clinical trials
Janet B McGill
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
April 15, 2014
The SGLT2 Inhibitor Empagliflozin for the Treatment of Type 2 Diabetes Mellitus: a Bench to Bedside Review
Janet B McGill
Postgraduate Medicine
|
June 12, 2014
Anti-diabetes therapy: safety considerations for patients with impaired kidney function
Janet B McGill
Medical Teacher
|
August 24, 2021
Using reflection to confront mistakes: Reframing failure for success
Raquel B McGill
Current Gastroenterology Reports
|
February 15, 2001
Liver biopsy: when, how, by whom, and where?
D B McGill
The Journal of Family Practice
|
September 12, 2009
Selecting among ADA/EASD tier 1 and tier 2 treatment options
Janet B McGill
Current Diabetes Reviews
|
April 21, 2012
Pharmacotherapy in type 2 diabetes: a functional schema for drug classification
Janet B McGill
Vascular Health and Risk Management
|
June 12, 2010
Optimal use of beta-blockers in high-risk hypertension: a guide to dosing equivalence
Janet B McGill
International Journal of Clinical Practice. Supplement
|
October 5, 2010
Liraglutide: effects beyond glycaemic control in diabetes treatment
J B McGill
Page
of 28